Secondary Cancer Risk of Radiotherapy and Imaging Examination for Two Different Malignancies in One Patient

Q3 Health Professions
Mohammad Hossein Zare, Hamidreza Masjedi, Fateme Tabatabaei, Shiva Rahbar Yazdi, Masoud Shabani, Mohammad Ali Broomand
{"title":"Secondary Cancer Risk of Radiotherapy and Imaging Examination for Two Different Malignancies in One Patient","authors":"Mohammad Hossein Zare, Hamidreza Masjedi, Fateme Tabatabaei, Shiva Rahbar Yazdi, Masoud Shabani, Mohammad Ali Broomand","doi":"10.18502/fbt.v10i4.13732","DOIUrl":null,"url":null,"abstract":"Purpose: Radiotherapy (RT), which is considered one of the critical treatments for cancer patients is also known as adjuvant therapy and palliative care, and can be attempted alone or concurrent with chemotherapy. Although RT reduces the risk of recurrence, the scattered dose may enhance the risk of secondary cancer induction; this is raising some challenges in clinical practice. To the best of our knowledge, few studies to date have assessed such effects of brain cancer adjuvant radiotherapy.
 Materials and Methods: We estimated the RT-induced risk of secondary cancer for a 45-year-old patient who had undergone radiotherapy of the head and pelvis with a 6 MV photon beam in 15 and 10 sessions, respectively. The absorbed dose by the thyroid, breast, eye lenses, region overlying ovaries, and parotids was measured using Thermoluminescent Dosimeters (TLD). Since the patient was scanned before radiotherapy, it was decided to calculate their risk as well. To evaluate the cancer risk, radiobiological models for Excess Absolute Risk (EAR), as well as Excess Relative Risk (ERR) published by the Committee on the Biological Effects of Ionizing Radiation (BEIR) in report VII, were implemented. This study thus aimed to estimate the Risk of Exposure-Induced Death (REID) and assess the radiation dose delivered to patients from Computed Tomography (CT) scans and common diagnostic nuclear medicine examinations.
 Results: The mean risk of secondary cancer for sensitive organs was calculated 3 years after radiotherapy. The highest estimated ERR was related to the region overlying right and left ovaries for pelvic radiotherapy (47.82) and (51.17), and the next highest EAR followed by right and left eye lenses for brain radiotherapy (18.09) and (15.43), respectively. In addition, other cancers arising from CT scans had the highest REID values for solid cancer (0.0015) and bone scans revealed the highest REID values for other cancers (0.00121).
 Conclusion: Calculating the corresponding risks of RT is of great significance for the patients in procedural change. Choosing proper field sizes and adapted techniques to avoid excessive doses to healthy organs can thus be a great assistance in this regard.","PeriodicalId":34203,"journal":{"name":"Frontiers in Biomedical Technologies","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Biomedical Technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/fbt.v10i4.13732","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Radiotherapy (RT), which is considered one of the critical treatments for cancer patients is also known as adjuvant therapy and palliative care, and can be attempted alone or concurrent with chemotherapy. Although RT reduces the risk of recurrence, the scattered dose may enhance the risk of secondary cancer induction; this is raising some challenges in clinical practice. To the best of our knowledge, few studies to date have assessed such effects of brain cancer adjuvant radiotherapy. Materials and Methods: We estimated the RT-induced risk of secondary cancer for a 45-year-old patient who had undergone radiotherapy of the head and pelvis with a 6 MV photon beam in 15 and 10 sessions, respectively. The absorbed dose by the thyroid, breast, eye lenses, region overlying ovaries, and parotids was measured using Thermoluminescent Dosimeters (TLD). Since the patient was scanned before radiotherapy, it was decided to calculate their risk as well. To evaluate the cancer risk, radiobiological models for Excess Absolute Risk (EAR), as well as Excess Relative Risk (ERR) published by the Committee on the Biological Effects of Ionizing Radiation (BEIR) in report VII, were implemented. This study thus aimed to estimate the Risk of Exposure-Induced Death (REID) and assess the radiation dose delivered to patients from Computed Tomography (CT) scans and common diagnostic nuclear medicine examinations. Results: The mean risk of secondary cancer for sensitive organs was calculated 3 years after radiotherapy. The highest estimated ERR was related to the region overlying right and left ovaries for pelvic radiotherapy (47.82) and (51.17), and the next highest EAR followed by right and left eye lenses for brain radiotherapy (18.09) and (15.43), respectively. In addition, other cancers arising from CT scans had the highest REID values for solid cancer (0.0015) and bone scans revealed the highest REID values for other cancers (0.00121). Conclusion: Calculating the corresponding risks of RT is of great significance for the patients in procedural change. Choosing proper field sizes and adapted techniques to avoid excessive doses to healthy organs can thus be a great assistance in this regard.
一名患者两种不同恶性肿瘤的放射治疗和影像学检查的继发癌风险
目的:放疗(RT)被认为是癌症患者的关键治疗方法之一,也被称为辅助治疗和姑息治疗,可以单独或与化疗同时进行。虽然放疗降低了复发风险,但分散剂量可能会增加继发性癌诱导的风险;这给临床实践带来了一些挑战。据我们所知,迄今为止很少有研究评估脑癌辅助放疗的这种效果。材料和方法:我们估计了一名45岁患者的继发性癌症风险,该患者分别接受了15次和10次6 MV光子束的头部和骨盆放射治疗。用热释光剂量计(TLD)测定甲状腺、乳房、眼晶状体、卵巢上覆区域和腮腺的吸收剂量。由于患者在放射治疗前进行了扫描,因此决定也计算他们的风险。为了评估癌症风险,采用了电离辐射生物效应委员会(BEIR)在报告VII中公布的超绝对风险(EAR)和超相对风险(ERR)的放射生物学模型。因此,本研究旨在估计暴露诱发死亡(REID)的风险,并评估计算机断层扫描(CT)扫描和普通诊断核医学检查给患者的辐射剂量。结果:计算放疗后3年敏感器官继发癌的平均危险度。估计ERR最高的是骨盆放疗的左右卵巢覆盖区域(47.82)和(51.17),其次是脑放疗的左右眼晶状体(18.09)和(15.43)。此外,CT扫描引起的其他癌症实体癌的REID值最高(0.0015),骨扫描显示其他癌症的REID值最高(0.00121)。 结论:计算相应的RT风险对手术改变患者有重要意义。因此,选择适当的场大小和适应的技术以避免对健康器官的过量剂量可以在这方面提供很大的帮助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Biomedical Technologies
Frontiers in Biomedical Technologies Health Professions-Medical Laboratory Technology
CiteScore
0.80
自引率
0.00%
发文量
34
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信